A randomized cross-over trial of prebiotics and probiotics in multiple sclerosis: Trial feasibility, supplement tolerability and symptom abatement

Straus Farber, R., Walker, E. L., Diallo, F., Onomichi, K., Riley, C., Zhang, L., Zhu, W., De Jager, P. L., & Xia, Z. (2024). A randomized cross-over trial of prebiotics and probiotics in multiple sclerosis: Trial feasibility, supplement tolerability and symptom abatement. Multiple Sclerosis and Related Disorders, 89, 105762. https://doi.org/10.1016/j.msard.2024.105762
Authors:
Rebecca Straus Farber
Elizabeth Ls Walker
Fatoumata Diallo
Kaho Onomichi
Claire Riley
Lili Zhang
Wen Zhu
Philip L De Jager
Zongqi Xia
Affiliated Authors:
Rebecca Straus Farber
Fatoumata Diallo
Kaho Onomichi
Claire Riley
Philip L De Jager
Columbia Affiliation:
Subjects:
Probiotics (MeSH)
Prebiotics (MeSH)
Cross-Over Studies (MeSH)
Multiple Sclerosis, Relapsing-Remitting (MeSH)
Feasibility Studies (MeSH)
Author Keywords:
bowel function
dietary supplement
microbiome
prebiotics
probiotics
randomized trial
elink
Publication Type:
Article
Unique ID:
10.1016/j.msard.2024.105762
PMID:
39047340
DOI:
10.1016/j.msard.2024.105762
Journal:
Multiple Sclerosis and Related Disorders
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record
View Web of Science Record
View Scopus Record

Record Created: